| Dr Jessica Frederiksen, PHARMD | |
|
145 N Miles St, Appleton, MN 56208-1316 | |
| (320) 289-1252 | |
| (320) 289-2691 |
| Full Name | Dr Jessica Frederiksen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 145 N Miles St, Appleton, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720462377 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 118101 (Minnesota) | Primary |
| 183500000X | Pharmacist | 5320 (South Dakota) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Frederiksen, PHARMD 145 N Miles St, Appleton, MN 56208-1316 Ph: (320) 289-1252 | Dr Jessica Frederiksen, PHARMD 145 N Miles St, Appleton, MN 56208-1316 Ph: (320) 289-1252 |
News Archive
The Obama Administration Tuesday released some much anticipated rules that will govern the types of benefits insurers must offer in policies sold after 2014 and rules on how they can design wellness programs.
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.
In response to U.S. House passage of the health care bill (H.R. 3962), Small Business & Entrepreneurship Council (SBE Council) president & CEO Karen Kerrigan issued the following statement.
On Monday, USAID Administrator Rajiv Shah "announced the launch of the agency's first-ever policy and program guidance on Building Resilience to Recurrent Crisis during an event in Washington, D.C.," according to an USAID press release.
› Verified 8 days ago